端粒酶各组分在肿瘤细胞分化过程中的表达和调控研究

基本信息
批准号:39970855
项目类别:面上项目
资助金额:15.00
负责人:丁健
学科分类:
依托单位:中国科学院上海药物研究所
批准年份:1999
结题年份:2002
起止时间:2000-01-01 - 2002-12-31
项目状态: 已结题
项目参与者:蒋建飞,刘卫军,汤涛,陆丽娟,杨蔚怡
关键词:
端粒酶分化肿瘤
结项摘要

The methods to detect the mRNA level of hTERT, hTR, hTP1 and hTERT mRNA splicing variants were established .On the base , the molecular mechanism of telomerase regulation in tumor cell differentiation and cell apoptosis induced by drugs and the effect of DNA-damageing drugs on telomerase activity were studied. In all-trans-retinoic acid (ATRA)-induced , human leukemia HL-60 cells differentiation, telomerase activity was down-regulated associated with a decrease in hTERT mRNA and an increase in hTP1 mRNA. However, the alternative splicing of hTERT mRNA may not contribute to the suppression of telomerase activity induced by ATRA. On the other hand, we investigated the relationship between telomerase activity and anti-cancer effect of DNA damaging anti-tumor drugs on human lung adenocarcinoma A549 cells . The results suggested that salvicine, a novel topoisomerase II inhibitor developed in our institute, may partly perform its function through modulation of telomerase activity by dephosphorylation of telomerase components, and the decrease of telomerase activity is an early and specific response to salvicine-treatment compared with other DNA damaging drugs. In the subsequent project, the model of apoptosis induction by salvicine was used to reveal the change of telomerase activity in cell apoptosis. Telomerase activity was also down-rgulated in salvicine-induced HL-60 cell apoptosis, and protein phosphatase PP2A was activated at the same time. The results collectively suggested that the salvicine-induced decline in telomerase activity may be principally by the dephophorylation of twlomerase components mediated by PP2A.

建立端粒酶各组分hTRT, hTR, TP1的基因表达半定量测定技术;利用恶性肿瘤细胞株分化模型,主要是白血病和肝癌细胞株,研究其分化逆转过程中端粒酶活力及其相关基因的表达调节;构建c-fos表达载体转染肿瘤细胞系,研究其和端粒酶催化亚基hTRT表达的相关性。此钛芯慷杂诮沂径肆C傅募せ罨疲髌湓谥琢龇⑸⒄构讨械淖饔糜兄匾庖澹币参滦涂拱┮┪锒肆C敢种萍恋目⑻峁└嗟睦砺垡谰荨

项目摘要

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

结直肠癌免疫治疗的多模态影像及分子影像评估

结直肠癌免疫治疗的多模态影像及分子影像评估

DOI:10.13609/j.cnki.1000-0313.2022.04.019
发表时间:2022
2

肺部肿瘤手术患者中肺功能正常吸烟者和慢阻肺患者的小气道上皮间质转化

肺部肿瘤手术患者中肺功能正常吸烟者和慢阻肺患者的小气道上皮间质转化

DOI:
发表时间:2019
3

宫颈癌发生与ApoE、CLU和RelB表达调控 的关系及意义

宫颈癌发生与ApoE、CLU和RelB表达调控 的关系及意义

DOI:10.3870/j.issn.1672-8009.2016.03.004
发表时间:2016
4

基于分子对接和网络药理学的连翘抗肿瘤的作用机制分析

基于分子对接和网络药理学的连翘抗肿瘤的作用机制分析

DOI:10.19540/j.cnki.cjcmm.20200428.601
发表时间:2020
5

树突状表皮T细胞调节小鼠表皮干细胞增殖和分化促进小鼠全层皮肤缺损创面愈合的机制研究

树突状表皮T细胞调节小鼠表皮干细胞增殖和分化促进小鼠全层皮肤缺损创面愈合的机制研究

DOI:10.3760/cma.j.cn501120-20200623-00324
发表时间:2020

丁健的其他基金

批准号:30730103
批准年份:2007
资助金额:150.00
项目类别:重点项目
批准号:30330670
批准年份:2003
资助金额:150.00
项目类别:重点项目
批准号:31771371
批准年份:2017
资助金额:60.00
项目类别:面上项目
批准号:31800574
批准年份:2018
资助金额:25.00
项目类别:青年科学基金项目
批准号:21606106
批准年份:2016
资助金额:20.00
项目类别:青年科学基金项目
批准号:91229205
批准年份:2012
资助金额:400.00
项目类别:重大研究计划
批准号:39670840
批准年份:1996
资助金额:10.00
项目类别:面上项目
批准号:30271513
批准年份:2002
资助金额:21.00
项目类别:面上项目
批准号:81801930
批准年份:2018
资助金额:21.00
项目类别:青年科学基金项目

相似国自然基金

1

肿瘤细胞基因表达的调控与细胞生长和分化的关系

批准号:38880018
批准年份:1988
负责人:宋增璇
学科分类:C0704
资助金额:6.00
项目类别:专项基金项目
2

端粒酶在肿瘤细胞凋亡过程中的分子调控机制研究

批准号:30271513
批准年份:2002
负责人:丁健
学科分类:H3505
资助金额:21.00
项目类别:面上项目
3

肿瘤细胞中端粒酶催化亚基hEST2 基因表达的调控机制

批准号:39870783
批准年份:1998
负责人:黄君健
学科分类:H1801
资助金额:10.00
项目类别:面上项目
4

肿瘤相关粒细胞调控浆细胞分化和功能的机制研究

批准号:31470855
批准年份:2014
负责人:邝栋明
学科分类:C0805
资助金额:85.00
项目类别:面上项目